Search

Your search keyword '"Lees KR"' showing total 645 results

Search Constraints

Start Over You searched for: Author "Lees KR" Remove constraint Author: "Lees KR"
645 results on '"Lees KR"'

Search Results

1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

3. Safety and outcomes of routine endovascular thrombectomy in large artery occlusion recorded in the SITS Register: An observational study

4. Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group

5. Does the cognitive measure Cog-4 show improvement among patients treated with thrombolysis after acute stroke?

6. Stroke aetiological classification reliability and effect on trial sample size: systematic review, meta-analysis and statistical modelling

7. Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal Dysphagia: Results from a Prospective Exploratory Study

8. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data.

9. Effects of alteplase for acute stroke according to criteria defining the EU and US marketing authorizations: individual-patient-data meta-analysis of randomized trials

10. Analyses of thrombi in acute ischemic stroke: A consensus statement on current knowledge and future directions

11. Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: results from the RAF-study (Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation)

12. Predicting disability after ischemic stroke based on comorbidity index and stroke severity-from the virtual international stroke trials archive-acute collaboration

13. Small vessel disease and clinical outcomes after IV rt-PA treatment

14. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack

15. Dependency and health utilities in stroke: Data to inform cost-effectiveness analyses

16. Determinants of post-stroke cognitive impairment: analysis from VISTA

17. What are the risks of intracerebral haemorrhage due to alteplase after acute ischaemic stroke? Results from an individual patient data meta-analysis of randomised trials

18. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack

19. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): A partial-factorial randomised controlled trial

20. Impact of heart rate on admission on mortality and morbidity in acute ischaemic stroke patients - results from VISTA

21. time to treatment with intravenous alteplase and outcome in stroke: un updated pooled analysis of Ecass, Atlantis, Ninds, and Epithet trials

22. thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stoke

23. Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development

25. State of Acute Endovascular Therapy Report From the 12th Thrombolysis, Thrombectomy, and Acute Stroke Therapy Conference

26. Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial

27. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

29. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

30. Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

34. Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis

35. Fourth European stroke science workshop

37. Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy A Validation Study of Home Time as an Outcome Measure

38. Comparison of Outcomes Following Thrombolytic Therapy Among Patients With Prior Stroke and Diabetes in the Virtual International Stroke Trials Archive (VISTA)

39. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack

40. Relative effects of statin therapy on stroke and cardiovascular events in men and women: Secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study

Catalog

Books, media, physical & digital resources